Altogether, these suggest that p27kip1 is a potent inhibitor of cell cycle progression in human β-cells, and may contribute, at least in part, to the decreased proliferative response observed in T2D human β-cells. This evidence concerns the gene CDKN1B and type 2 diabetes mellitus.